DoctorDirectory.ai
Menu

Dr. Robert Toto, MD

Not yet claimed

Nephrologist, Diabetes doctor, Hypertension specialist · Physician (MD)

Dallas, TX

Not yet claimed. This listing was researched from public sources and screened against our eligibility rules, but the provider has not yet claimed it, verified the details, or attested to guideline-based care. Are you Robert Toto? Claim this profile.

Dr. Robert Toto is a kidney doctor and professor at UT Southwestern Medical Center in Dallas. His work focuses on chronic kidney disease, and he has written extensively on kidney disease research.

About Dr. Robert Toto, MD

Updated Sep 20, 2026 · next review Dec 19, 2026

Dr. Robert D. Toto is a kidney doctor (nephrologist) at UT Southwestern Medical Center in Dallas, Texas. He joined the UT Southwestern faculty in July 1983 and holds the title of Mary M. Conroy Professor of Kidney Disease in the Division of Nephrology, along with Distinguished Teaching Professor. (https://profiles.utsouthwestern.edu/profile/17371/robert-toto.html)

His clinical and research work focuses on kidney disease caused by high blood pressure and diabetes, as well as cholesterol problems and anemia in chronic kidney disease and dialysis patients. A UT Southwestern article says he has written more than 250 articles and textbook chapters on kidney disease. (https://profiles.utsouthwestern.edu/profile/17371/robert-toto.html, https://www.utsouthwestern.edu/ctplus/stories/2026/erp26-40-robert-toto.html)

Besides seeing patients, he holds administrative and research leadership roles at UT Southwestern, including Associate Dean for clinical and translational research, Director of the Center for Translational Medicine, and Medical Director of the Multi-Specialty Clinic. He has served on the editorial boards of several kidney journals. (https://utswmed.org/doctors/robert-toto/, https://profiles.utsouthwestern.edu/profile/17371/robert-toto.html)

Federal CMS Open Payments records for 2021–2025 list $60,653.87 to him across 48 records, with the largest amounts from AstraZeneca UK Limited, Amgen, Novo Nordisk, Alnylam Pharmaceuticals, and Calliditas Therapeutics. Payments from drug and device companies to physicians are common and legal, and often reflect research or consulting work. (https://openpaymentsdata.cms.gov/)

Medical school and training
He earned his medical degree from the University of Illinois College of Medicine in 1977, trained in internal medicine at the University of Michigan and Baylor College of Medicine, and completed nephrology fellowship training including at UT Southwestern. profiles.utsouthwestern.edu
Endowed professorship
He is the Mary M. Conroy Professor of Kidney Disease and a Distinguished Teaching Professor at UT Southwestern, where he has been on faculty since 1983. profiles.utsouthwestern.edu
Kidney, diabetes and blood pressure focus
His listed research topics include kidney disease from high blood pressure and diabetes, cholesterol problems in chronic kidney disease, and anemia in kidney disease and dialysis. profiles.utsouthwestern.edu
Journal editorial boards
He has served on the editorial boards of Kidney International, the Journal of the American Society of Nephrology, the American Journal of Kidney Diseases, and other kidney journals. profiles.utsouthwestern.edu
Clinical trial publications
He is a co-author on a cardiovascular outcomes trial of linagliptin published in JAMA and on 2025 analyses of dapagliflozin and kidney function decline in the Clinical Journal of the American Society of Nephrology. doximity.com
Research leadership roles
He is Associate Dean for clinical and translational research in the Graduate School of Biomedical Sciences, Director of the Center for Translational Medicine, and Medical Director of the Multi-Specialty Clinic. utswmed.org
Hospitals and clinic
Listed hospital affiliations include William P. Clements Jr. University Hospital, Parkland Health, and UT Southwestern Zale Lipshy Pavilion; he is listed at the UT Southwestern Kidney & Liver Disease Clinic on N. St. Paul St. in Dallas. doctor.webmd.com
Industry payments on record
CMS Open Payments lists $60,653.87 across 48 records from 2021 through 2025, with the largest totals from AstraZeneca UK Limited, Amgen, and Novo Nordisk. openpaymentsdata.cms.gov
Nephrology NPI registration
His NPI, 1245209725, is registered under the nephrology taxonomy code 207RN0300X. npidb.org

Worth knowing

  • Board certification could not be independently confirmed in the sources reviewed. A Doximity profile shows a certification block, but the specific certifications were not retrievable. Patients can verify certification directly with ABIM/ABMS or the Texas Medical Board. doximity.com
  • Online listings do not fully agree on details. One aggregator shows his credential as 'DMD' rather than MD under the same NPI, and UT Southwestern pages list slightly different versions of his associate dean title. topnpi.com
  • His Doximity page appears to be unclaimed, so information there may not have been reviewed or updated by him. doximity.com

Industry payments (CMS Open Payments)

Open the CMS record

Federal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.

2021 to 2025

$60,654

48 payments

2021$14,615
2022$9,306
2023$9,177
2024$15,690
2025$11,866

Top payers

  • AstraZeneca UK Limited$16,338
  • Amgen Inc.$8,697
  • Novo Nordisk AS$8,102
  • Alnylam Pharmaceuticals Inc.$6,670
  • Calliditas Therapeutics US Inc.$4,865

Payment types

  • Consulting Fee$49,846
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$9,575
  • Food and Beverage$1,141
  • Travel and Lodging$93

A word of caution about these numbers

A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.

As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.

Sources: utswmed.org · profiles.utsouthwestern.edu · utsouthwestern.edu · doximity.com · researchgate.net · healthgrades.com · doctor.webmd.com · directory.dmagazine.com. Something wrong or out of date? Tell us and we will correct it.

Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.

Practice location

Something wrong with this profile? ·